A Phase 3 Prospective Multi-Center Single-Arm Open-Label Study to Evaluate VeraCept a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy Safety and Tolerability

A Phase 3  Prospective  Multi-Center  Single-Arm  Open-Label Study to Evaluate VeraCept  a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy  Safety  and Tolerability
Recruiting
18 years - 45 years
Female
Phase 3
200 participants needed
1 Location

Brief description of study

A research study for woman of child bearing age or potential and interested in using an intrauterine device (IUD) for birth control for up to 5 years.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Contraceptive
  • Age: 18 years - 45 years
  • Gender: Female


Updated on 04 Aug 2024. Study ID: 831931

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center